tirzepatide 2.5mg injection TrimRX tirzepatide 2 5 mg Tirzepatide

Most users pick a consistent day and time for convenience and adherence

However, risk increases significantly when combined with insulin or sulfonylureas

Trial SURPASS-5 (JAMA 2022) Population 475 adults with T2D + insulin glargine

While tirzepatide does not directly target thyroid function, substantial weight loss may affect thyroid hormone requirements in patients on thyroid replacement therapy, as is generally observed with significant weight changes

Lower-quality compounders may have potency variations that affect outcomes

For instance, significant gastrointestinal side effects leading to dehydration, or episodes of hypoglycaemia in susceptible individuals, might produce dizziness or light-headedness that patients interpret as vertigo